Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
IRTC

IRTC - iRhythm Technologies Inc Stock Price, Fair Value and News

88.29USD-6.64 (-6.99%)Delayed

Market Summary

IRTC
USD88.29-6.64
Delayed
-6.99%

IRTC Alerts

  • 1 major insider sales recently.

IRTC Stock Price

View Fullscreen

IRTC RSI Chart

IRTC Valuation

Market Cap

2.7B

Price/Earnings (Trailing)

-21.13

Price/Sales (Trailing)

5.35

EV/EBITDA

-21.04

Price/Free Cashflow

-24.27

IRTC Price/Sales (Trailing)

IRTC Profitability

Operating Margin

66.96%

EBT Margin

-25.19%

Return on Equity

-143.94%

Return on Assets

-14.29%

Free Cashflow Yield

-4.12%

IRTC Fundamentals

IRTC Revenue

Revenue (TTM)

513.2M

Rev. Growth (Yr)

18.39%

Rev. Growth (Qtr)

-0.44%

IRTC Earnings

Earnings (TTM)

-130.0M

Earnings Growth (Yr)

-16.77%

Earnings Growth (Qtr)

-18.01%

Breaking Down IRTC Revenue

Last 7 days

-10.8%

Last 30 days

-14.2%

Last 90 days

-21.1%

Trailing 12 Months

-12.7%

How does IRTC drawdown profile look like?

IRTC Financial Health

Current Ratio

7.1

Debt/Equity

0.39

Debt/Cashflow

-2.04

IRTC Investor Care

Shares Dilution (1Y)

2.08%

Diluted EPS (TTM)

-4.22

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024513.2M000
2023430.0M452.1M472.8M492.7M
2022340.9M361.7M380.1M410.9M
2021275.9M306.3M319.8M322.8M
2020229.8M228.2M245.5M265.2M
2019163.8M181.0M197.2M214.6M
2018108.8M120.3M133.7M147.3M
201772.7M80.8M89.0M98.5M
201641.9M48.8M56.2M64.1M
201525.3M28.9M32.5M36.1M
201400021.7M
IRTC
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
 CEO
 WEBSITEirhythmtech.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES1793

iRhythm Technologies Inc Frequently Asked Questions


What is the ticker symbol for iRhythm Technologies Inc? What does IRTC stand for in stocks?

IRTC is the stock ticker symbol of iRhythm Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of iRhythm Technologies Inc (IRTC)?

As of Fri Jul 26 2024, market cap of iRhythm Technologies Inc is 2.75 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IRTC stock?

You can check IRTC's fair value in chart for subscribers.

Is iRhythm Technologies Inc a good stock to buy?

The fair value guage provides a quick view whether IRTC is over valued or under valued. Whether iRhythm Technologies Inc is cheap or expensive depends on the assumptions which impact iRhythm Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IRTC.

What is iRhythm Technologies Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, IRTC's PE ratio (Price to Earnings) is -21.13 and Price to Sales (PS) ratio is 5.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IRTC PE ratio will change depending on the future growth rate expectations of investors.